tiprankstipranks
Amgen (AMGN)
NASDAQ:AMGN
US Market

Amgen (AMGN) Income Statement

Compare
6,327 Followers

Amgen Income Statement

Last quarter (Q4 2024), Amgen's total revenue was $9.09B, an increase of 10.86% from the same quarter last year. In Q4, Amgen's net income was $627.00M. See Amgen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 33.42B$ 28.19B$ 26.32B$ 25.98B$ 25.42B
Gross Profit
$ 20.57B$ 19.77B$ 19.92B$ 19.52B$ 19.27B
Operating Expenses
$ 13.31B$ 11.88B$ 10.35B$ 10.38B$ 10.13B
Depreciation and Amortization
$ 5.59B$ 4.07B$ 3.26B$ 3.40B$ 3.60B
EBITDA
$ 15.69B$ 14.70B$ 12.09B$ 12.54B$ 12.93B
Operating Income
$ 7.26B$ 7.90B$ 5.33B$ 6.00B$ 5.79B
Other Income/Expenses
$ -2.65B$ -42.00M$ 2.01B$ 696.00M$ -1.01B
Pretax Income
$ 4.61B$ 7.86B$ 7.35B$ 6.70B$ 8.13B
Net Income
$ 4.09B$ 6.72B$ 6.55B$ 5.89B$ 7.26B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 7.56$ 12.56$ 12.18$ 10.34$ 12.40
Diluted EPS
$ 7.56$ 12.49$ 12.11$ 10.28$ 12.31
Weighted Average Shares Outstanding
541.01M 535.00M 538.00M 570.00M 586.00M
Weighted Average Shares Outstanding (Diluted)
541.00M 538.00M 541.00M 573.00M 590.00M
Currency in USD

Amgen Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis